227 related articles for article (PubMed ID: 27391061)
1. Triptolide inhibits cell growth and GRP78 protein expression but induces cell apoptosis in original and radioresistant NPC cells.
Li C; Zhang B; Lv W; Lai C; Chen Z; Wang R; Long X; Feng X
Oncotarget; 2016 Aug; 7(31):49588-49596. PubMed ID: 27391061
[TBL] [Abstract][Full Text] [Related]
2. Triptolide inhibits Epstein-Barr nuclear antigen 1 expression by increasing sensitivity of mitochondria apoptosis of nasopharyngeal carcinoma cells.
Zhou H; Liu Y; Wang C; Liu L; Wang H; Zhang Y; Long C; Sun X
J Exp Clin Cancer Res; 2018 Aug; 37(1):192. PubMed ID: 30111354
[TBL] [Abstract][Full Text] [Related]
3. Triptolide Induces Apoptosis and Synergizes with Cisplatin in Cisplatin-Resistant HNE1/DDP Nasopharyngeal Cancer Cells.
Wang X; Zhang JJ; Sun YM; Zhang J; Wang LR; Li JC; Liu H
Folia Biol (Praha); 2015; 61(5):195-202. PubMed ID: 26667576
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of miR-144 by triptolide enhanced p85α-PTEN complex formation causing S phase arrest of human nasopharyngeal carcinoma cells.
Wu CW; Wang SG; Lin ML; Chen SS
Eur J Pharmacol; 2019 Jul; 855():137-148. PubMed ID: 31059711
[TBL] [Abstract][Full Text] [Related]
5. Triptolide induces apoptosis and inhibits the growth and angiogenesis of human pancreatic cancer cells by downregulating COX-2 and VEGF.
Ma JX; Sun YL; Wang YQ; Wu HY; Jin J; Yu XF
Oncol Res; 2013; 20(8):359-68. PubMed ID: 23924856
[TBL] [Abstract][Full Text] [Related]
6. Triptolide Inhibits Invasion and Tumorigenesis of Hepatocellular Carcinoma MHCC-97H Cells Through NF-κB Signaling.
Wang H; Ma D; Wang C; Zhao S; Liu C
Med Sci Monit; 2016 May; 22():1827-36. PubMed ID: 27239780
[TBL] [Abstract][Full Text] [Related]
7. Triptolide induces S phase arrest via the inhibition of cyclin E and CDC25A and triggers apoptosis via caspase- and mitochondrial-dependent signaling pathways in A375.S2 human melanoma cells.
Hung FM; Chen YL; Huang AC; Hsiao YP; Yang JS; Chung MT; Chueh FS; Lu HF; Chung JG
Oncol Rep; 2013 Mar; 29(3):1053-60. PubMed ID: 23314229
[TBL] [Abstract][Full Text] [Related]
8. Synergistic antitumour effects of triptolide plus 10-hydroxycamptothecin onbladder cancer.
Wang T; Ding Y; Yang Y; Wang Z; Gao W; Li D; Wei J; Sun Y
Biomed Pharmacother; 2019 Jul; 115():108899. PubMed ID: 31063955
[TBL] [Abstract][Full Text] [Related]
9. Triptolide Combined with Radiotherapy for the Treatment of Nasopharyngeal Carcinoma via NF-κB-Related Mechanism.
Zhang W; Kang M; Zhang T; Li B; Liao X; Wang R
Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27999372
[TBL] [Abstract][Full Text] [Related]
10. The Inhibition Effect of Triptolide on Human Endometrial Carcinoma Cell Line HEC-1B: a in vitro and in vivo Studies.
Ni J; Wu Q; Sun ZH; Zhong J; Cai Y; Huang XE
Asian Pac J Cancer Prev; 2015; 16(11):4571-6. PubMed ID: 26107205
[TBL] [Abstract][Full Text] [Related]
11. Synergistic effect of triptolide combined with 5-fluorouracil on colon carcinoma.
Tang XY; Zhu YQ; Tao WH; Wei B; Lin XL
Postgrad Med J; 2007 May; 83(979):338-43. PubMed ID: 17488865
[TBL] [Abstract][Full Text] [Related]
12. Triptolide Suppresses Alkali Burn-Induced Corneal Angiogenesis Along with a Downregulation of VEGFA and VEGFC Expression.
Wang G; Li N; Lv X; Ahmed N; Li X; Liu H; Ma J; Zhang Y
Anat Rec (Hoboken); 2017 Jul; 300(7):1348-1355. PubMed ID: 28233432
[TBL] [Abstract][Full Text] [Related]
13. Triptolide synergistically enhances temozolomide-induced apoptosis and potentiates inhibition of NF-κB signaling in glioma initiating cells.
Sai K; Li WY; Chen YS; Wang J; Guan S; Yang QY; Guo CC; Mou YG; Li WP; Chen ZP
Am J Chin Med; 2014; 42(2):485-503. PubMed ID: 24707876
[TBL] [Abstract][Full Text] [Related]
14. Identification of biomarkers for predicting nasopharyngeal carcinoma response to radiotherapy by proteomics.
Feng XP; Yi H; Li MY; Li XH; Yi B; Zhang PF; Li C; Peng F; Tang CE; Li JL; Chen ZC; Xiao ZQ
Cancer Res; 2010 May; 70(9):3450-62. PubMed ID: 20406978
[TBL] [Abstract][Full Text] [Related]
15. Triptolide synergistically enhances antitumor activity of oxaliplatin in colon carcinoma in vitro and in vivo.
Liu Y; Xiao E; Yuan L; Li G
DNA Cell Biol; 2014 Jul; 33(7):418-25. PubMed ID: 24720675
[TBL] [Abstract][Full Text] [Related]
16. A new curcumin analogue exhibits enhanced antitumor activity in nasopharyngeal carcinoma.
Pan Y; Xiao J; Liang G; Wang M; Wang D; Wang S; Yang H
Oncol Rep; 2013 Jul; 30(1):239-45. PubMed ID: 23673810
[TBL] [Abstract][Full Text] [Related]
17. Triptolide triggers the apoptosis of pancreatic cancer cells via the downregulation of Decoy receptor 3 expression.
Wang W; Li X; Sun W; Zhang L; Zhang M; Hong B; Lv G
J Cancer Res Clin Oncol; 2012 Sep; 138(9):1597-605. PubMed ID: 22581262
[TBL] [Abstract][Full Text] [Related]
18. Triptolide enhances TRAIL sensitivity of pancreatic cancer cells by activating autophagy via downregulation of PUM1.
Dai H; Jiang Y; Luo Y; Bie P; Chen Z
Phytomedicine; 2019 Sep; 62():152953. PubMed ID: 31128486
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of β-Catenin Decreases the Radiosensitivity of Human Nasopharyngeal Carcinoma CNE-2 Cells.
He H; Lin K; Su Y; Lin S; Zou C; Pan J; Zhou Y; Chen C
Cell Physiol Biochem; 2018; 50(5):1929-1944. PubMed ID: 30396174
[TBL] [Abstract][Full Text] [Related]
20. Novel target genes responsive to the anti-growth activity of triptolide in endometrial and ovarian cancer cells.
Li H; Takai N; Yuge A; Furukawa Y; Tsuno A; Tsukamoto Y; Kong S; Moriyama M; Narahara H
Cancer Lett; 2010 Nov; 297(2):198-206. PubMed ID: 20547442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
